SCHEMBL480515

SCHEMBL480515

CCOC(=O)c1ccc2c(c1)NC(=O)C2=C(C)Nc1ccc(C(C)(C)N)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.48
MAPT P10636 8/20 0.45
RAB9A P51151 6/20 0.43
NPC1 O15118 4/20 0.43
GAA P10253 4/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
PDK1 Q15118 1/20 0.40
PDK2 Q15119 1/20 0.40
PDK3 Q15120 1/20 0.40
PDK4 Q16654 1/20 0.40
TP53 P04637 3/20 0.40
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
IDO1 P14902 1/20 0.40
TDO2 P48775 1/20 0.40
POLB P06746 1/20 0.40
KDM4E B2RXH2 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TRPV1 Q8NER1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2119777 0.90 KMT2A (0.46) RXFP1MAPTRAB9ANPC1TP53
SCHEMBL2118011 0.89 RXFP1 (0.47) RXFP1MAPTRAB9ANPC1GAA
SCHEMBL2573629 0.89 RXFP1 (0.49) RXFP1MAPTRAB9ANPC1GAA
SCHEMBL479335 0.88 RXFP1 (0.46) RXFP1MAPTRAB9ANPC1GAA
SCHEMBL2119767 0.84 RXFP1 (0.42) RXFP1MAPTRAB9ANPC1GAA
SCHEMBL2569840 0.83 RXFP1 (0.45) RXFP1MAPTRAB9ANPC1GAA
SCHEMBL480512 0.83 RXFP1 (0.45) RXFP1MAPTRAB9ANPC1GAA
SCHEMBL2568413 0.83 RXFP1 (0.44) RXFP1MAPTRAB9ANPC1GAA
SCHEMBL480592 0.83 RXFP1 (0.47) RXFP1MAPTRAB9ANPC1GAA
SCHEMBL479845 0.82 RXFP1 (0.47) RXFP1MAPTRAB9ANPC1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9844572-B2 Promotion of neuronal integration in neural stem cell grafts LIFE & BRAIN GMBH (DE) 2017-12-19 US disclosed
EP-2411034-B1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS LIFE & BRAIN GMBH (DE) 2017-07-26 EP disclosed
US-20120093832-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS LIFE & BRAIN GMBH (DE) 2012-04-19 US disclosed
EP-2411034-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS Life & Brain GmbH (DE) 2012-02-01 EP disclosed
WO-2010108665-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS LIFE & BRAIN GMBH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120093832-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS DCX, NGF, BDNF RXFP1 2731/4885MAPT 960/4885RAB9A 1246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.